Anticorps Monoclonal anti-BAG3

BAG3 Monoclonal Antibody for WB, IF/ICC, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, Lapin, porc, rat, souris

Applications

WB, IF/ICC, ELISA

Conjugaison

Non conjugué

CloneNo.

4G6C2

N° de cat : 68076-1-PBS

Synonymes

4G6C2, BAG-3, Bcl-2-associated athanogene 3, Bcl-2-binding protein Bis, BIS



Informations sur le produit

68076-1-PBS cible BAG3 dans les applications de WB, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain, Lapin, porc, rat, souris

Réactivité Humain, Lapin, porc, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène BAG3 Protéine recombinante Ag17608
Nom complet BCL2-associated athanogene 3
Masse moléculaire calculée 61 kDa
Poids moléculaire observé74 kDa
Numéro d’acquisition GenBankBC006418
Symbole du gène BAG3
Identification du gène (NCBI) 9531
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

BAG3 (Bcl2-associated athanogene 3) belongs to the BAG protein family, the co-chaperone that binds to Hsc70/Hsp70 through the BAG domain and modulates their activity in polypeptide folding. BAG3 contains also a WW domain and a proline-rich (PXXP) repeat, that mediate binding to partners different from Hsp70. Through interacting with different molecular partner, BAG3 influences several cell processes, such as apoptosis, autophagy and cell motility. BAG3 protein has been reported to sustain cell survival, resistance to therapy, and/or motility and metastatization in several tumor types, thus being identified as a potential target for anticancer therapies. In addition, defects in BAG3 are the cause of some myopathy.

{{ptg:RelatedPrimaryAntibodies}}